Suchergebnisse - "Usmani, Saad Z"

PubPharm (49)

1

SOHO State of the Art Updates and Next Questions : Will CAR-T Replace ASCT in NDMM

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Jurgens, E. | Usmani, S.

2

Addressing the disparities : the approach to the African American patient with multiple myeloma

enthalten in: Blood cancer journal | 2023

von Bhutani, M. | Blue, B. | Cole, C. | +5

3

The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies

enthalten in: Hematology/oncology clinics of North America | 2023

von Nath, K. | Mailankody, S. | Usmani, S.

4

Expert Consensus on the Incorporation of Anti-CD38 Monoclonal Antibody Therapy Into the Management of Newly Diagnosed Multiple Myeloma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Lonial, S. | Bowser, A. | Chari, A. | +3

5

Aiming for the cure in myeloma : Putting our best foot forward

enthalten in: Blood reviews | 2023

von Bar, N. | Firestone, R. | Usmani, S.

6

Cilta-cel, a BCMA-targeting CAR-T therapy for heavily pretreated patients with relapsed/refractory multiple myeloma

enthalten in: Future oncology (London, England) | 2023

von Martin, T. | Madduri, D. | Pacaud, L. | +1

7

Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma : Recommendations from a Multidisciplinary Roundtable Discussion

enthalten in: Transplantation and cellular therapy | 2023

von Bashir, Q. | Braunstein, M. | Buck, T. | +9

8

An Embarrassment of Riches : Three FDA-Approved Bispecific Antibodies for Relapsed Refractory Multiple Myeloma

enthalten in: Blood cancer discovery | 2023

von Firestone, R. | Lesokhin, A. | Usmani, S.

9

BCMA-Targeted Biologic Therapies : The Next Standard of Care in Multiple Myeloma Therapy

enthalten in: Drugs | 2022

von Paul, B. | Rodriguez, C. | Usmani, S.

10

Extramedullary disease in multiple myeloma : a systematic literature review

enthalten in: Blood cancer journal | 2022

von Bladé, J. | Beksac, M. | Caers, J. | +8

1
2
3
4
5
Nächster »
[5]